In the past week, MGRM stock has gone up by 26.51%, with a monthly gain of 18.42% and a quarterly plunge of -32.69%. The volatility ratio for the week is 9.23%, and the volatility levels for the last 30 days are 8.02% for Monogram Orthopaedics Inc The simple moving average for the past 20 days is 12.96% for MGRM’s stock, with a -22.04% simple moving average for the past 200 days.
Is It Worth Investing in Monogram Orthopaedics Inc (NASDAQ: MGRM) Right Now?
There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The public float for MGRM is 16.42M, and at present, short sellers hold a 0.37% of that float. The average trading volume of MGRM on November 20, 2023 was 31.68K shares.
MGRM) stock’s latest price update
Monogram Orthopaedics Inc (NASDAQ: MGRM) has experienced a rise in its stock price by 13.72 compared to its previous closing price of 2.77. However, the company has seen a gain of 26.51% in its stock price over the last five trading days. Seeking Alpha reported 2023-08-18 that Monogram Orthopaedics, Inc. went public in May 2023 and raised $17.2 million for its autonomous robotic surgical system for knee replacement surgery. The company is still in the development stage and will require significant additional capital to fund its plans. The stock is an ultra-high-risk investment, and my outlook is to Sell.
MGRM Trading at 11.73% from the 50-Day Moving Average
After a stumble in the market that brought MGRM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.57% of loss for the given period.
Volatility was left at 8.02%, however, over the last 30 days, the volatility rate increased by 9.23%, as shares surge +12.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.84% lower at present.
During the last 5 trading sessions, MGRM rose by +26.51%, in comparison to the 20-day moving average, which settled at $2.81. In addition, Monogram Orthopaedics Inc saw -73.19% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MGRM
The total capital return value is set at -250.49, while invested capital returns managed to touch -331.38. Equity return is now at value -357.82, with -122.21 for asset returns.
Based on Monogram Orthopaedics Inc (MGRM), the company’s capital structure generated 14.71 points at debt to equity in total, while total debt to capital is 12.82. Total debt to assets is 4.46, with long-term debt to equity ratio resting at 11.88. Finally, the long-term debt to capital ratio is 10.34.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.24.
Conclusion
In summary, Monogram Orthopaedics Inc (MGRM) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
